PR Newswire
LOS ANGELES
, Feb. 4, 2025 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Kyverna Therapeutics, Inc. (“Kyverna” or “the Company”) (NASDAQ: KYTX) for violations of the federal securities laws.
Shareholders who purchased the Company’s securities pursuant and/or traceable to the Company’s offering documents issued in connection with its initial public offering (“IPO”) conducted on February 8, 2024, are encouraged to contact the firm before February 7, 2025.
CASE DETAILS: The Company allegedly made false and misleading statements to the market regarding being in possession of adverse data related to one of its ongoing trials. Kyverna’s lead product was negatively impacted by the undisclosed adverse data, which made the trends and disclosed results in the offering documents misleading. The Company’s discussion of risk factors failed to adequately describe the risk of it withholding clinical data.
If you are a shareholder who suffered a loss, contact us to participate.
WHY DJS LAW GROUP? DJS Law Group’s primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/final-deadline-for-the-kyverna-therapeutics-inc-securities-lawsuit—contact-the-djs-law-group-to-discuss-your-rights—kytx-302367238.html
SOURCE DJS Law Group LLP
